Inotiv, Inc. — Director's Dealing 2019

Mar 1, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2019-02-28

Reporting Person: Leasure Robert Jr. (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-28	Common Shares	P	8900	$1.51	Acquired	79615	Direct
2019-03-01	Common Shares	P	10000	$1.62	Acquired	89615	Direct

Footnotes

F1: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.49 to $1.55, inclusive. The reporting person undertakes to provide to Bioanalytical Systems, Inc., any security holder of Bioanalytical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.56 to $1.65, inclusive. The reporting person undertakes to provide to Bioanalytical Systems, Inc., any security holder of Bioanalytical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.